Back to search
FDAFDA · Food and drugs·Recall number D-0765-2021

FLUDARABINE PHOSPHATE FOR INJECTION, USP, 50 mg per vial, Single dose vial, Rx Only, Mfd for: Leucadia Pharmaceuticals Carlsbad, CA 92011 U.S.A, NDC 24201-237-01

Published September 1, 2021 · Recall initiated: July 30, 2021

Summary

FDA records drug Class II recall D-0765-2021, published September 1, 2021 and initiated July 30, 2021. Recalling firm: Custopharm, Inc.; Status: Terminated; Reported quantity: 19,384 vials; Lot: Lot# 31327913C, Exp. Date 10/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: the manufacturing firm had microbial recoveries during environmental monitoring in aseptic areas of manufacturing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Custopharm, Inc.
Distributor
Distributed Nationwide in the USA
Lot
Lot# 31327913C, Exp. Date 10/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was FLUDARABINE PHOSPHATE FOR INJECTION, USP, 50 mg per vial, Single dose vial, Rx Only, Mfd for: Leucadia Pharmaceuticals Carlsbad, CA 92011 U.S.A, NDC 24201-237-01 recalled?

Yes. FDA published recall D-0765-2021 on September 1, 2021. Reported hazard: Lack of Assurance of Sterility: the manufacturing firm had microbial recoveries during environmental monitoring in aseptic areas of manufacturing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter